News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,439 Results
Type
Article (8021)
Company Profile (140)
Press Release (476277)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166761)
Career Advice (305)
Deals (25741)
Drug Delivery (7)
Drug Development (52876)
Employer Resources (14)
FDA (9761)
Job Trends (8575)
News (238246)
Policy (17922)
Tag
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (485)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33154)
ALS (104)
Alzheimer's disease (974)
Antibody-drug conjugate (ADC) (262)
Approvals (10368)
Artificial intelligence (320)
ASCO (159)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (6958)
BIO (36)
BIOSECURE Act (1)
Biosimilars (108)
BioSpace Insights (18)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (28)
Breast cancer (507)
Cancer (3628)
Cardiovascular disease (217)
Career advice (245)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (476)
Cervical cancer (34)
Clinical research (47847)
Collaboration (1240)
Commercialization (3)
Compensation (1449)
Complete response letters (34)
COVID-19 (754)
CRISPR (63)
C-suite (738)
Cystic fibrosis (85)
Data (5625)
Denatured (4)
Depression (102)
Dermatology (60)
Diabetes (341)
Diagnostics (4179)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (156)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (163)
Earnings (73674)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87581)
Executive appointments (697)
FDA (12367)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (910)
Gene editing (125)
Generative AI (10)
Gene therapy (315)
GLP-1 (290)
Government (941)
Grass and pollen (2)
Guidances (281)
Healthcare (9314)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (156)
Infectious disease (942)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (253)
Interviews (41)
IPO (12387)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Licensing (7)
Liver cancer (44)
Longevity (15)
Lung cancer (505)
Lymphoma (249)
Machine learning (27)
Management (3)
Manufacturing (528)
Marketing (8)
MASH (118)
Medical device (8650)
Medtech (8790)
Mergers & acquisitions (14379)
Metabolic disorders (706)
mRNA (53)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (38)
Neuroscience (1818)
NextGen: Class of 2026 (3150)
Non-profit (841)
Obesity (225)
Opinion (10)
Ovarian cancer (158)
Pain (170)
Pancreatic cancer (195)
Parkinson's disease (201)
Partnered (12)
Patents (472)
Patient recruitment (502)
Peanut (31)
People (41210)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15458)
Phase 2 (21369)
Phase 3 (14390)
Pipeline (7234)
Policy (18)
Postmarket research (1570)
Preclinical (6537)
Press Release (34)
Prostate cancer (189)
Psychedelics (7)
Radiopharmaceuticals (190)
Rare diseases (569)
Real estate (3019)
Recruiting (6)
Regulatory (14791)
Reports (19)
Research institute (581)
Resumes & cover letters (45)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (99)
Series A (152)
Series B (121)
Service/supplier (5)
Sickle cell disease (62)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2019)
Stomach cancer (3)
Supply chain (50)
Vaccines (318)
Venture capital (17)
Weight loss (73)
Women's health (78)
Date
Today (107)
Last 7 days (455)
Last 30 days (1673)
Last 365 days (19134)
2026 (12072)
2025 (19252)
2024 (22990)
2023 (26541)
2022 (34589)
2021 (37167)
2020 (33468)
2019 (23256)
2018 (17468)
2017 (18765)
2016 (17920)
2015 (24268)
2014 (21679)
2013 (18135)
2012 (20221)
2011 (20440)
2010 (20333)
Location
Africa (228)
Alabama (73)
Alaska (2)
Arizona (300)
Arkansas (11)
Asia (17879)
Australia (2097)
California (11906)
Canada (3125)
China (517)
Colorado (481)
Connecticut (407)
Delaware (207)
Europe (24615)
Florida (1780)
Georgia (375)
Hawaii (3)
Idaho (46)
Illinois (695)
India (48)
Indiana (314)
Iowa (14)
Japan (398)
Kansas (101)
Kentucky (30)
Louisiana (26)
Maine (26)
Maryland (1193)
Massachusetts (7825)
Michigan (307)
Minnesota (559)
Mississippi (4)
Missouri (80)
Montana (20)
Nebraska (11)
Nevada (114)
New Hampshire (60)
New Jersey (2610)
New Mexico (12)
New York (2811)
North Carolina (1267)
North Dakota (4)
Northern California (5962)
Ohio (276)
Oklahoma (14)
Oregon (16)
Pennsylvania (2244)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (76)
South Dakota (1)
Southern California (4942)
Tennessee (119)
Texas (1924)
United States (38672)
Utah (358)
Vermont (1)
Virginia (152)
Washington D.C. (38)
Washington State (920)
West Virginia (1)
Wisconsin (73)
484,439 Results for "septerna inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Septerna Highlights Business Progress and Reports Second Quarter 2026 Financial Results
August 10, 2026
·
9 min read
Press Releases
Septerna Highlights Business Progress and Reports First Quarter 2026 Financial Results
May 12, 2026
·
9 min read
Press Releases
Septerna to Present at Bank of America Securities Health Care Conference 2026
May 5, 2026
·
1 min read
Press Releases
Septerna to Present Preclinical Characterization of SEP-479, an Oral PTH1R Agonist for Hypoparathyroidism, at 2026 ENDO Annual Meeting
June 8, 2026
·
5 min read
Press Releases
Septerna to Present at TD Cowen 46th Annual Health Care Conference
February 24, 2026
·
1 min read
Press Releases
Septerna Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2025 Financial Results
March 9, 2026
·
10 min read
Press Releases
Septerna Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - February 10, 2026
February 11, 2026
·
1 min read
Press Releases
Septerna Announces Initiation of Phase 1 Clinical Trial of SEP-479, an Oral Small Molecule PTH1R Agonist for the Treatment of Hypoparathyroidism
April 13, 2026
·
6 min read
Press Releases
Septerna to Participate in 8th Annual Evercore Healthcare Conference
November 26, 2025
·
1 min read
Press Releases
Septerna to Present at 44th Annual J.P. Morgan Healthcare Conference
December 18, 2025
·
1 min read
1 of 48,444
Next
